"Trust in God" Episode 2 - An interview with Dr Jeyanthi Kunadhasan

Dr Jeyanthi Kunadhasan is an experienced anaesthetist and peri-operative physician.
She received her Bachelor of Medicine from the National University of Malaysia

and a Post graduate degree in Anaesthesia from the University Malaya (UM).

She is a Fellow of the Australian and New Zealand College of Anaesthetists (FANZSCA).

She also has a Masters in Peri-operative Medicine from Monash University.

She was a Consultant Anaesthetist at a major regional Victorian public hospital, and was in practice for more than 12 years up until she was fired for not taking the Covid vaccine.
Dr. Kunadhasan joined the Australian Medical Professionals Society (AMPS), which is a union of doctors in Australia who resisted mandatory COVID vaccination and were willing to speak up for their convictions. She is part of the executive.

In addition to joining AMPS, Dr. Kunadhasan immediately answered the call from Dr. Naomi Wolf and Mr. Steve Bannon, when they requested volunteers to study the newly released Pfizer documents. Dr. Kunadhasan has been instrumental in researching the documents and published significant findings.

This is our second interview with Dr Kunadhasan, and this interview focuses solely on Pfizer’s efficacy calculation for their vaccine and what the Daily Clout team discovered was the actual timeline of the accrual of the cases in 2020.

In this episode, we discuss the following:

- Dr Jeyanthi joined a group of volunteers, studying the newly released Pfizer documents in May 2022. She tells us the documents were released as part of a court order in 2022 due to a successful lawsuit by lawyer Aaron Siri. The US FDA and Pfizer had asked the court to keep these documents sealed for 75 years. It is 500 000 documents. These documents are publicly available on a website called www.phmpt.org - Public Health Medical Professionals for Transparency.

The volunteer group is called Warroom/DailyClout Pfizer Documents Analysis Volunteers.

- We discuss the work Dr Jeyanthi did with her team at DailyClout on investigating the 170 triallists who were selected to make up the efficacy calculation for the Pfizer trial. How did Pfizer select them? Her team established a spreadsheet with all their criteria, including when they tested positive for Covid. Pfizer Had Data to Announce Its COVID-19 Vaccine’s Alleged “Efficacy” in October 2020. Why Did Pfizer Delay the Announcement until November 9, 2020, Six Days after the 2020 U.S. Presidential Election? (see report 76 in References section below).

- We review the timeline of the accrual of cases, as revealed by Pfizer to the world. Of note is that during October 2020, the rate of accrual of cases was less then one a day, despite the fact that more then half the cohort were eligible. Then suddenly, between October 31 to November 8 the rate was 4 cases/day.
Then note the gradient between November 8 to November 14 was 12 cases/day.

This is what Pfizer made the world believe.

These patients were recruited from many countries and across both hemispheres, so this was not about a sudden covid outbreak in one city. It looks like the October cases were hidden to ensure an interim result of efficacy could NOT be announced before the US election. Note the 2020 US presidential election was Nov 6, 2020.

- Pfizer had committed to doing an interim result at 32 cases. However on Oct 29, 2 days before the contract with the US government was due, Pfizer announced they would NOT do an interim report of efficacy at 32 cases and instead would do it’s first interim report at 62 cases. Pfizer stated it did not have 62 cases at that point. This was not true. The Daily Clout team discovered that on Oct 29, Pfizer had 94 cases. The protocol amendment is called Protocol 9.

-We discuss the 2 contracts that the US government had with Pfizer. The original contract was for $2 billion and 100 million doses was to be delivered by October 31. The second contract was for $10 billion and 500 million doses. The second contract references the 170 patients and the 95% efficacy. (the contracts can be found in Report 76, see below).

Papers and Websites referenced in the Interview;

- Public Health Medical Professionals for Transparency, website. (Contains the Pfizer documents that were released by the court).
https://phmpt.org/

- Kunadhasan, Jeyanthi, and colleagues. “Report 42: Pfizer’s EUA Granted Based on Fewer than 0.4% of Clinical Trial Participants. FDA Ignored Disqualifying Protocol Deviations to Grant Eua.” DailyClout, 26 Sept. 2022

https://dailyclout.io/report-41-the-170-clinical-trial-participants-who-changed-the-world-pfizer-ignored-protocol-deviations-to-obtain-emergency-use-authorization-for-its-covid-19-mrna-vaccine/

- Kunadhasan, Jeyanthi, and Ed Clark. “Report 76: Pfizer Had Data to Announce Its COVID-19 Vaccine’s Alleged “Efficacy” in October 2020. Why Did Pfizer Delay the Announcement until November 9, 2020, Six Days after the 2020 U.S. Presidential Election?”

https://dailyclout.io/report-76-pfizer-had-necessary-data-to-announce-its-covid-19-vaccines-alleged-efficacy-in-october-2020-why-did-pfizer-delay/